Toward better risk stratification of asymptomatic Brugada syndrome patients?

Najla Beydoun¹, Charbel Gharios², Marwan M Refaat^{3

4}

Affiliations

¹ Department of Anesthesiology and Perioperative Medicine, Tufts Medical Center, Boston, Massachusetts, USA.
² Cardiovascular Imaging Research Center, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
³ Division of Cardiology, Department of Internal Medicine, American University of Beirut Faculty of Medicine and Medical Center, Beirut, Lebanon.
⁴ Department of Biochemistry and Molecular Genetics, American University of Beirut Faculty of Medicine and Medical Center, Beirut, Lebanon.

Editorial

Najla Beydoun et al. J Cardiovasc Electrophysiol. 2021 Nov.

. 2021 Nov;32(11):3008-3009.

doi: 10.1111/jce.15261. Epub 2021 Oct 5.

Najla Beydoun¹, Charbel Gharios², Marwan M Refaat^{3

4}

¹ Department of Anesthesiology and Perioperative Medicine, Tufts Medical Center, Boston, Massachusetts, USA.
² Cardiovascular Imaging Research Center, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
³ Division of Cardiology, Department of Internal Medicine, American University of Beirut Faculty of Medicine and Medical Center, Beirut, Lebanon.
⁴ Department of Biochemistry and Molecular Genetics, American University of Beirut Faculty of Medicine and Medical Center, Beirut, Lebanon.

No abstract available

Keywords: Brugada syndrome; cardiac arrhythmias; cardiovascular diseases; electroanatominal mapping; heart diseases; risk stratification.

Comment on

Right ventricular outflow tract electroanatomical abnormalities in asymptomatic and high-risk symptomatic patients with Brugada syndrome: Evidence for a new risk stratification tool?
Letsas KP, Vlachos K, Conte G, Efremidis M, Nakashima T, Duchateau J, Bazoukis G, Frontera A, Mililis P, Tse G, Cheniti G, Takigawa M, Pambrun T, Prappa E, Sacher F, Derval N, Sideris A, Auricchio A, Jais P, Haissaguerre M, Hocini M. Letsas KP, et al. J Cardiovasc Electrophysiol. 2021 Nov;32(11):2997-3007. doi: 10.1111/jce.15262. Epub 2021 Oct 7. J Cardiovasc Electrophysiol. 2021. PMID: 34596938

1. Antzelevitch C, Brugada P, Borggrefe M, et al. Brugada syndrome: report of the second consensus conference: endorsed by the Heart Rhythm Society and the European Heart Rhythm Association. Circulation. 2005;111(5):659-670. doi:10.1161/01.Cir.0000152479.54298.51
1. Sroubek J, Probst V, Mazzanti A, et al. Programmed ventricular stimulation for risk stratification in the Brugada syndrome: a pooled analysis. Circulation. 2016;133(7):622-630. doi:10.1161/circulationaha.115.017885
1. Kusumoto FM, Bailey KR, Chaouki AS, et al. Systematic review for the 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Heart Rhythm. 2018;15(10):e253-e274. doi:10.1016/j.hrthm.2017.10.037
1. Pappone C, Ciconte G, Manguso F, et al. Assessing the malignant ventricular arrhythmic substrate in patients with Brugada syndrome. J Am Coll Cardiol. 2018;71(15):1631-1646. doi:10.1016/j.jacc.2018.02.022
1. Frustaci A, Priori SG, Pieroni M, et al. Cardiac histological substrate in patients with clinical phenotype of Brugada syndrome. Circulation. 2005;112(24):3680-3687. doi:10.1161/circulationaha.105.520999